Benjamin M. Craig, Ph.D. March 18, 2015 Curriculum Vitae for: Benjamin M. Craig, Ph.D. Date: March 18, 2015 Current Position: Current Academic Appointments: Associate Member Health Outcomes & Behavior Program Division of Population Sciences Moffitt Cancer Center 12902 Magnolia Drive Tampa, FL, USA 33612 Phone: (813) 745-6710 Fax: (813) 745-6525 [email protected] http://labpages.moffitt.org/craigb/ Associate Professor Department of Economics College of Arts and Sciences University of South Florida 4202 E. Fowler Avenue, CMC206A Tampa, Florida, USA 33620 Associate Professor Department of Oncologic Sciences, MDC 44 College of Medicine University of South Florida 12901 Bruce B. Downs Blvd. Tampa, Florida, USA 33612 Education 2003 1999 1995 Ph.D. Population Health, University of Wisconsin-Madison, Madison, Wisconsin, USA M.S. Economics, University of Texas at Austin, Austin, Texas, USA B.A. Economics, University of Wisconsin-Madison, Madison, Wisconsin, USA Academic Appointments and Employment 2007-Present 2013-Present 2013-Present 2008-2013 2007-2013 2011 Associate Professor , Department of Economics, College of Arts and Sciences, University of South Florida, Tampa, Florida, USA Associate Professor, Department of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, Florida, USA Associate Member, Health Outcomes & Behavior, Division of Population Science, Moffitt Cancer Center, Tampa, Florida, USA Assistant Professor, Department of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, Florida, USA Assistant Member [tenure-track], Health Outcomes & Behavior, Division of Population Science, Moffitt Cancer Center, Tampa, Florida, USA Visiting Scholar, Health Economics Research Unit, Division of Applied Health Sciences, College of Life Sciences and Medicine, University of Aberdeen, Aberdeen, Scotland, UK Page 1 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 2009 2006-2007 2005-2006 2003-2006 2003-2006 1999-2003 1996-1999 1996-1999 1995-1996 Visiting Scholar, Health Economics and Decision Sciences, School of Health and Related Research, University of Sheffield, Sheffield, England, UK Visiting Assistant Professor, Department of Family Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA Visiting Scholar, Sonderegger Research Center, School of Pharmacy, University of Wisconsin, Madison, Wisconsin, USA Assistant Professor [tenure-track], Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, Arizona, USA Associate Investigator, Arizona Cancer Center, Arizona Health Sciences Center, University of Arizona, Tucson, Arizona, USA AHRQ Pre-doctoral Trainee, Department of Population Health Sciences, Medical School, University of Wisconsin-Madison, Madison, Wisconsin, USA Graduate Research Assistant, Department of Economics, College of Arts and Sciences, University of Texas at Austin, Austin, Texas, USA Graduate Teaching Assistant, Department of Economics, College of Arts and Sciences, University of Texas at Austin, Austin, Texas, USA Research Fellow, Department of Applied and Agricultural Economics, College of Agricultural and Life Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA Teaching Experience University Courses: Fall 2013 Spring 2013 Fall 2005 Fall 2005 Spring 2005 Fall 2004 Fall 2004 Summer 2004 Spring 2004 Fall 2003 Fall 2003 Fall 2003 Instructor: Economics of Health Care (ECP6536), University of South Florida, Tampa, Florida, USA Guest Speaker: Health Economics II (PubH 6832), University of Minnesota, Minneapolis, Minnesota, USA Instructor/Coordinator: Health Technology Assessment (PhSc513), University of Arizona, Tucson, Arizona, USA Instructor/Coordinator: Medication Use and the U.S. Health Care System (PhPr 445), University of Arizona, Tucson, Arizona, USA Guest Speaker: Applied Health Technology Assessment (PhSc 613), University of Arizona, Tucson, Arizona, USA Instructor/Coordinator: Health Technology Assessment (PhSc 513), University of Arizona, Tucson, Arizona, USA Instructor/Coordinator: Medication Use and the U.S. Health Care System (PhPr 445), University of Arizona, Tucson, Arizona, USA Instructor/Coordinator: Introduction to Microeconomic Theory (PhSc 599), University of Arizona, Tucson, Arizona, USA Guest Speaker: Applied Health Technology Assessment (PhSc 613), University of Arizona, Tucson, Arizona, USA Guest Speaker: Professional Practice Management (PhPr 442), University of Arizona, Tucson, Arizona, USA Guest Speaker: Health Technology Assessment (PhSc 513), University of Arizona, Tucson, Arizona, USA Instructor: Medication Use and the U.S. Health Care System (PhPr 445), University of Arizona, Tucson, Arizona, USA Page 2 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 Other Courses and National Symposia Instructor/Coordinator: 2015 2014 2013 2012 2011 2010 2009 Use of Instrumental Variables in Observational Studies of Treatment Effects, International Society for Pharmacoeconomics and Outcomes Research, 18th Annual European Congress, Milan, Lombardy, Italy, November 8, 2015 (workshop). Instrumental Variables in Addressing Selection Bias in Observational Studies, International Society for Pharmacoeconomics and Outcomes Research, 20th Annual Meeting, Philadelphia, Pennsylvania, USA, May 17, 2015 (course). QALYs in Cost-Effectiveness and Benefit-Cost Analysis: How to be an Informed Consumer, Society for Benefit-Cost Analysis, Washington, District of Columbia, USA, March 18, 2015 (workshop). Discrete Choice Experiments: Enhancing PRO beyond QALY, Centre for Health Economics, Monash University, Clayton, Victoria, Australia, November 28, 2014 (workshop). Use of Instrumental Variables in Observational Studies of Treatment Effects, International Society for Pharmacoeconomics and Outcomes Research, 17th Annual European Congress, Amsterdam RAI, Amsterdam, the Netherlands, November 9, 2014 (workshop). Discrete Choice Experiments: Enhancing PRO beyond QALYs, International Society for Quality of Life Research, 21st Annual Conference, Berlin, Germany, October 15, 2014 (course). Discrete Choice Experiments on HRQoL: Enhancing PRO beyond QALYs, QALY Brazil, Rio de Janeiro, Brazil, March 13, 2014 (course). Instrumental Variables in Addressing Selection Bias in Observational Studies, International Society for Pharmacoeconomics and Outcomes Research, 19th Annual Meeting, Palais des Congrès de Montréal, Montreal, Quebec, Canada, June 1, 2014 (course). Instrumental Variables in Addressing Selection Bias in Observational Studies, International Society for Pharmacoeconomics and Outcomes Research, 16th Annual European Congress, The Convention Center Dublin, Dublin, Ireland, November 3, 2013 (course). Discrete Choice Experiments: Enhancing PRO beyond QALYs, International Society for Quality of Life Research, 20th Annual Conference, Miami, Florida, USA, October 9, 2013 (course). Instrumental Variables in Addressing Selection Bias in Observational Studies, International Society for Pharmacoeconomics and Outcomes Research, 18th Annual Meeting, New Orleans, Louisiana, USA, May 19, 2013 (course). Introduction to Database Analysis of Observational Studies of Treatment Effects, International Society for Pharmacoeconomics and Outcomes Research, 18th Annual Meeting, New Orleans, Louisiana, USA, May 18, 2013 (course). Instrumental Variables in Addressing Selection Bias in Observational Studies, International Society for Pharmacoeconomics and Outcomes Research, 15th Annual European Congress, ICC Berlin, Berlin, Germany, November 4, 2012 (course). Instrumental Variables in Addressing Selection Bias in Observational Studies, International Society for Pharmacoeconomics and Outcomes Research, 17th Annual Meeting, Washington Hilton, Washington, District of Columbia, USA, June 1, 2012 (course). Online Experimental Techniques, Moffitt Cancer Center, Tampa, Florida, USA, May 5, 2011 (workshop). Instrumental Variables in Addressing Selection Bias in Observational Studies, International Society for Pharmacoeconomics and Outcomes Research, 17th Annual Meeting, Atlanta, Georgia, USA, May 15, 2010 (course). Instrumental Variables in Addressing Selection Bias in Observational Studies, International Society for Pharmacoeconomics and Outcomes Research, 16th Annual Meeting, Orlando, Florida, USA, May 16, 2009 (course). Page 3 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 2008 2008 2007 Instrumental Variables in Addressing Selection Bias in Observational Studies, International Society for Pharmacoeconomics and Outcomes Research, 15th Annual Meeting, Toronto, Ontario, Canada, May 3, 2008 (course). Instrumental Variables in Addressing Selection Bias in Observational Studies, Moffitt Cancer Center, Tampa, Florida, USA, February 28, 2008 (workshop). Basics of Statistics, Fellows Research Conference, University of Wisconsin, Department of Nephrology, Madison, Wisconsin, USA, October 24, 2007 (course). Teaching and Training Experience Graduate Training: 2014-present 2014-present 2009-present 2014-2015 2010-2013 2012-2013 2009-2011 2008-2009 2008 2003-2006 2003-2006 John Hartman, Department of Economics, University of South Florida, Tampa, Florida, USA. Currently mentoring. Nicole Schoenecker, Department of Economics, University of South Florida, Tampa, Florida, USA. Currently serving as member of Dissertation Committee. Shannon Runge, Aging Studies Program, University of South Florida, Tampa, Florida, USA. Currently mentoring. Kathleen McFadden, College of Medicine, University of South Florida, Tampa, Florida, USA. Mentored in my lab for 1 year. Larry Kessler, Department of Economics, University of South Florida, Tampa, Florida, USA. Served as member of Dissertation Committee and mentored for 3 years. Berna Colak, Department of Economics, University of South Florida, Tampa, Florida, USA. Mentored in my lab for 1 year. Andrea Collado, Department of Economics, University of South Florida, Tampa, Florida, USA. Mentored in my lab for 2 years. Taiwo Abimbola, Department of Economics, University of South Florida, Tampa, Florida, USA. Mentored in my lab for 2 years. Melissa Mugharbel, Department of Economics, University of South Florida, Tampa, Florida, USA. Mentored in my lab for 1 year. Sulabha Ramachandran, Department of Pharmacy Practice and Science, University of Arizona, Tucson, Arizona, USA. Served as member of Masters and Dissertation Committees. J. Jason Lundy, Department of Pharmacy Practice and Science, University of Arizona, Tucson, Arizona, USA. Served as member of Masters Committee. Student Advising: 2014-present 2013-present 2013-present 2012-present 2012-2014 2011-2013 2011-2013 2008-2011 2009-2010 Michael Stepanski, University of Miami, Coral Gables, Florida, USA. Currently mentoring. Nawreen Jahan, University of South Florida, Tampa, Florida, USA. Currently mentoring. Mazin Ibrahim, University of South Florida, Tampa, Florida, USA. Currently mentoring. Catherine Blackburn, University of South Florida, Tampa, Florida, USA. Currently mentoring. Mary Tomaino, University of South Florida, Tampa, Florida, USA. Mentored for 2 years. Zein Kattih, University of South Florida, Tampa, Florida, USA. Mentored for 2 years. Janel Phetteplace, University of South Florida, Tampa, Florida, USA. Mentored for 2 years. Riddhi Patel, University of South Florida, Tampa, Florida, USA. Mentored for 3 years. Ayesha Farooq, University of South Florida, Tampa, Florida, USA. Mentored for 2 years. Page 4 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 Honors and Awards 2011 2005-2006 Outstanding Faculty Performance in Basic and Population Science awarded by Moffitt Cancer Center. Research Starter Grant in Health Outcomes awarded by Pharmaceutical Research and Manufacturers of America Foundation. Research Support Current External Grants: Grant Account: PI: Dates: Source: Title: % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: R01-CA160104 Craig, BM 09/09/2011-06/30/2016 NCI HRQoL Values for Cancer Survivors: Enhancing PROMIS Measures for CER 35% Principal Investigator $ 2,091,804 $ 3,129,188 Education Grants: Grant Account: PI: Dates: Source: Title: % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: R25-CA147832 Egan, KM 07/01/2010-6/30/2015 NCI Moffitt Postdoctoral Training Program in Molecular & Genetic Epidemiology 0% Program Faculty $ 1,865,926 $ 2,015,200 Completed External Grants: Grant Account: PI: Dates: Source: Title: % Effort: Role in the Study: U54-CA153509 Meade, CD and Gwede, CK 09/03/2010-08/31/2015 NCI Tampa Bay Community Cancer Network Research Project: Colorectal Cancer Awareness, Research Education, and Screening 2% Co-Investigator Contributions include the proposal and advising on the design, conduct and publication of a cost-effectiveness study. Page 5 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 Total Direct Costs Total Amount of Award: $ 1,314,327 $ 2,194,926 Grant Account: PI: Dates: Source: Title: % Effort: Role in the Study: R01-CA134347 Brandon, T 05/11/2009-03/31/2014 NCI Extended self-help for smoking cessation 8% Co-Investigator Contributions include the proposal, design, conduct and publication of a cost-effectiveness study. $ 2,060,340 $ 3,440,768 $ 32,253 Total Direct Costs: Total Amount of Award: Total Amount of Award: Grant Account: PI: Dates: Source: Title: % Effort: Role in the Study: Total Direct Costs: Unassigned, Moffitt Foundation Craig, BM 07/1/2013-12/31/2013 EuroQol Group The Relationship between Time, Sequencing and Precision: Considerations for Choice Experiments 0% Principal Investigator $ 32,253 Grant Account: PI: Dates: Source: Title: % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: Unassigned, Moffitt Foundation Craig, BM 07/1/2013-12/31/2013 EuroQol Group Preference Inversion in the EQ-5D-5L 0% Principal Investigator $ 11,957 $ 11,957 Grant Account: PI: Dates: Source: Title: % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: R01-CA137357 Brandon, T 01/01/2009-11/30/2012 NCI Relapse-Prevention Booklets as Adjunct to a Tobacco Quitline 5% Co-Investigator Contributions include the proposal, design, conduct and publication of a cost-effectiveness study. $ 1,786,846 $ 2,808,995 Grant Account: PI: Dates: RC2-CA148332 Fenstermacher, D 09/29/2009-08/31/2012 Page 6 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 Source: Title: Total Direct Costs: Total Amount of Award: NCI Developing Information Infrastructure Focused on Cancer Comparative Effectiveness Research 5% Co-Investigator Contributions include the proposal, administration, design, conduct and publication of a value of information study and 3 secondary data analysis of Medicare claims. $ 1,231,132 $ 3,963,447 Grant Account: PI: Dates: Source: Title: % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: K25-CA122176 Craig, BM 09/01/2006-08/31/2011 NCI Obesity, Aging and Cancer Cost (OACC) Study 75% Principal Investigator $ 667,227 $ 720,604 Grant Account: PI: Dates: Source: Title: % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: 69-15539-01-01 Craig, BM 03/01/2009-2/28/2011 International Papillomavirus Society Pre-Conference on Modeling Evidence in HPV 1% Principal Investigator $ 200,000 $ 200,000 Grant Account: Co-PI: Dates: Source: Title: Unavailable Craig, BM and Cogle, C 03/01/2010-12/31/2010 Celgene Pilot Study of SEER-Medicare Database to Define Incidence of MDS 5% Co-Principal Investigator $ 60,673 $ 75,841 Effort: Role: % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: Grant Account: PI: Dates: Source: Title: % Effort: Role in the Study: R01-CA131080-01A2 Lengacher, C 09/22/2009-09/21/2010 NCI MBSR Symptom Cluster Trial for Breast Cancer Survivors 5% Co-Investigator Contributions include the proposal and advising on the design, conduct and publication of a cost-effectiveness study. Page 7 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 Total Direct Costs: Total Amount of Award: $ 593,504 Unknown Grant Account: PI/Co-PI: Dates: Source: Title: % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: P20-CA103676 Jacobsen, P 03/30/2009-08/31/2009 NCI Moffitt Aging and Cancer Prevention Program 8% Co-Investigator $ 623,519 $ 1,041,277 Grant Account: PI/Co-PI: Dates: Source: Title: 84-15482-99-01 Craig, BM 08/01/2008-12/31/2008 Merck Evidence Synthesis for Modeling the Natural History of HPV-related Anal, Penile and Oropharyngeal Cancers. 25% Principal Investigator $ 60,198 $ 99,928 % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: Grant Account: PI/Co-PI: Dates: Source: Title: % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: Grant Account: PI/Co-PI: Dates: Source: Title: Unavailable Goode, K 01/01/2007-12/31/2007 Community Pharmacy Foundation Evaluating Pharmacy Immunization in Community Settings (EPICS) 0% Co-Investigator Contributions include the proposal and design of a secondary data analysis of Medicare claims. Unavailable $ 50,526 Total Direct Costs: Total Amount of Award: HSR&D-unavailable Babcock-Parziale, J 04/01/2006-09/01/2006 [Withdrawn due to K-Award] Veterans Affairs Advancing Outcomes Measurement and Micro-costing in Blind Rehabilitation 20% Co-Investigator Contributed to proposal and design of cost-effectiveness study. Unavailable $ 508,053 Grant Account: PI/Co-PI: Dates: Health Outcomes-Research Starter Grant Craig, BM 01/01/2005-08/31/2006 % Effort: Role in the Study: Page 8 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 Source: Title: % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: Grant Account: PI/Co-PI: Dates: Source: Title: % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: Grant Account: PI/Co-PI: Dates: Source: Title: % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: PhRMA Economic Burden of Cancer borne by Patients, Medicare, and Other Payers, 1992-2001 10% Principal Investigator $ 60,000 $ 60,000 Unavailable Skrepnek, G 10/31/2004-09/30/2005 Eli Lilly An Analysis of the Clinical and Economic Consequences of Disease Management Programs for the Treatment of Schizophrenia and Diabetes 5% Co-Investigator Contributions include the proposal and design of a cost-effectiveness and secondary data analysis study. $ 125,044 $ 125,044 R03-HS013993 Craig, BM 08/01/2003-07/31/2004 [withdrawn due to completion of dissertation] Agency for Healthcare Research and Quality Out-of-pocket Price, Prescription Drugs, and the Elderly 100% Principal Investigator $ 30,000 $ 31,259 Education Grants: Grant Account: PI: Dates: Source: Title: Role in the Study: Total Amount of Award: 1D43TW008325 Giuliano, AR 08/08/2009-07/31/2010 Fogarty International Center Cancer Research Training in Morocco Program Faculty $ 27,000 Grant Account: PI: Dates: Source: Title: Role in the Study: Total Amount of Award: Unavailable Craig, BM 08/01/2005 CVS Pharmacy Sponsorship of Educational Materials Coordinator $ 279 Page 9 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 Grant Account: PI: Dates: Source: Title: Role in the Study: Total Amount of Award: Unavailable Craig, BM 11/01/2004 Caremark PCS Sponsorship of Educational Materials Coordinator $ 6,222 Consultant: Grant Account: PI: Dates: Source: Title: % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: Grant Account: PI: Dates: Source: Title: % Effort: Role in the Study: Total Direct Costs: Total Amount of Award: 200-2008-27958, TO 26 Trogdon, JG 09/01/2011 - 08/31/2013 CDC Economic Burden of Breast Cancer in Young Women Aged 15-44 Years in the United States, 2000-2010 0% Consultant Contributions include the proposal, design, conduct and publication of an outcomes study. $245,199 Unknown 200-2008-F-26463 Brown, DS 07/22/2008 – 07/31/2012 CDC Preference-Based Assessment of Child Maltreatment and Quality of Life 0% Consultant Contributions include the design, conduct and publication of a discrete choice experiment. $ 668,885 Unknown Dissertation 2003 Doctoral Thesis: Out-of-pocket Price, Prescription Medications, and Seniors. University of Wisconsin-Madison (Population Health), Madison, Wisconsin, USA. Thesis Advisors: John Mullahy, Ph.D. (chair), Dennis Fryback, Ph.D., Barbara Wolfe, Ph.D., David Kindig, M.D. Ph.D., David H. Kreling, Ph.D., David A. Mott, Ph.D. Service Moffitt Cancer Center: 2015-present 2012-present 2013-2014 Member, Total Cancer Care Team Science Committee. Member, Adolescent and Young Adult (AYA) Research Committee. Member, Junior Faculty Research Award Selection Committee. Page 10 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 2013-2014 2013-2014 2013-2014 2012-2013 2009-2012 2010-2011 2009 2008-2009 Member, Library Advisory Council. Member, Total Cancer Care Advisory Counsel. Member, Code of Ethics & Business Conduct Working Group. Member, Health Outcomes and Behavior Program Leader Advisory Committee. Member, Faculty Search Committee. Member, TCC Research Questions Taskforce. Member, Code of Ethics & Business Conduct Working Group. Member, Data Quality Executive Committee. Professional: 2014-Present 2014-Present 2014-Present 2013-Present 2013-Present 2005-Present 2015 2014 2014 2013-2014 2011-2012 2011-2012 2005-2010 2007, 2011 2009-2011 2009-2011 2009 2009 2008-2009 2008 2007-2008 2005-2006 2005-2006 2005-2006 Chair, International Academy of Health Preference Research Foundation, Inc. Co-Editor, EuroQol Working Papers Series (EQ WPS), EuroQol Research Foundation. Co-Chair, Health Preference Research Special Interest Group, International Society for Quality of Life Research (ISOQOL). Freelancer, EuroQol Research Foundation. Editorial Board Member, The Patient – Patient-Centered Outcomes Research. Editorial Board Member, Value & Outcomes Spotlight (formerly known as Connections), International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Reviewer, National Cancer Institute (NCI), Special Emphasis Panel, April 30, Bethesda, Maryland, USA. Reviewer, Agency for Healthcare Research and Quality (AHRQ), Special Emphasis Panel, November 13-14, Gaithersburg, Maryland, USA. Reviewer, Agency for Healthcare Research and Quality (AHRQ), Special Emphasis Panel, May 15-16, Gaithersburg, Maryland, USA. Member, Conjoint Analysis Special Interest Group, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Chair, Health Outcomes Metrics Educational Working Group, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Member, Organizing Committee, Fourth Conjoint Analysis in Healthcare conference. Member, Scientific Committee, American Society of Health Economist (ASHE). Member, Scientific Committee, International Health Economics Association (iHEA). Chair, Health Econometrics Working Group, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Executive Director, International HPV Modeling Group (IHMG). Reviewer, Challenge Grants, Center for Scientific Review, DHHS/NIH. Chair, Modeling Evidence in HPV, Preconference Meeting, 25th Conference, International Papillomavirus Society (IPVS). Co-Chair of the Workshop Review Committee, 14th Annual International Meeting, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Moderator, Podium Session II: Research on Medicare Part D and Reimbursement Policies II, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Member, ePRO Reviewer Group, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Chair, Contributed Poster Awards Task Force – Annual Meeting, Awards Committee, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Chair, Survey Subcommittee, Communications Task Force, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Member, Contributed Papers Awards Task Force – Annual Meeting, Awards Committee, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Page 11 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 2005-2006 2005-2006 Member, Economic Outcomes Reference Group, Using "Real World" Data in Coverage and Reimbursement Decisions Task Force, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Member, Evidence Hierarchies Reference Group, Using "Real World" Data in Coverage and Reimbursement Decisions Task Force, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Professional Association Memberships 2014-Present 2013-Present 2008-Present 2006-Present 2004-Present 2003-Present 2001-Present Member, International Academy of Health Preference Research (IAHPR) Member, International Society for Quality of Life Research (ISOQOL) Member, EuroQol Group (EQ) Member, American Society of Health Economist (ASHE) Member, American Society of Clinical Oncology (ASCO) Member, International Society of Pharmacoeconomics & Outcomes Research (ISPOR) Member, International Health Economics Association (iHEA) Journal Reviewer Health Economics Medical Care Journal of Clinical Oncology International Journal of Cancer PharmacoEconomics The Patient Economic Modeling American Journal of Health Economics Journal of Health Economics Quality of Life Research Cancer Psycho-Oncology Applied Health Economics and Health Policy Population Health Metrics Health Expectations Value in Health Leukemia Research Journal of the National Cancer Institute European Journal of Health Economics Field Methods PLOS ONE Peer-Reviewed Publications Forthcoming Papers 1. Craig BM, Greiner W, Brown DS, Reeve BB, Valuation of Child Health-Related Quality of Life in the United States, Health Economics. forthcoming 2. Craig BM, Brown DS, Reeve BB, Valuation of Child Behavioral Problems from the Perspective of US Adults. Medical Decision Making. forthcoming 3. Craig BM, Brown DS, Reeve BB, The Value Adults Place on Child Health and Functional Status. Value Health. forthcoming 4. Runge SK, Craig BM, Jim H. Word Recall: Cognitive Performance within Internet Surveys. Journal of Medical Internet Research Mental Health. forthcoming 5. Unrod M, Simmons VN, Sutton SK, Meltzer LR, Harrell PT, Meade CD, Craig BM, Lee JH, Brandon TH. Relapse-Prevention Booklets as an Adjunct to a Tobacco Quitline: A Randomized Controlled Effectiveness Trial. Nicotine & Tobacco Research. forthcoming 6. Lengacher CA, Reich RR, Kip KE, Craig BM, Mogos M, Ramesar S, Paterson CL, Farias JR, Pracht E. Cost-effectiveness of a mindfulness based stress reduction program for improving quality of life in breast cancer survivors: Results from a randomized control trial. Nursing Econ. forthcoming Page 12 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 Papers in PubMed: 1. Craig BM, Runge SK, Rand-Hendriksen K, Ramos-Goñi JM, Oppe M. Learning and satisficing: An analysis of sequence effects in health valuation. Value Health. 2015 Mar;18(2):217-23. Epub 2015 Feb 2. PMID: 25773557 [PubMed - in process] 2. Owens MA, Craig BM, Egan KM, Reed DR. Birth desires and intentions of women diagnosed with a meningioma. J Neurosurg. 2015 Jan; 27:1-6. PMID: 25623387 [Epub ahead of print]. 3. Craig BM, Pickard AS, Rand-Hendriksen K. Do health preferences contradict ordering of EQ-5D labels? Qual Life Res. 2014. Dec; 18. PMID: 25519940 [Epub ahead of print]. 4. Craig BM, Reeve BB, Brown PM, Cella D, Hays RD, Lipscomb J, Pickard S, Revicki DA. US valuation of health outcomes measured using the PROMIS-29. Value Health. 2014. Dec;17(8):846-53. PMID: 25498780. 5. Unrod M, Simmons VN, Sutton SK, Meltzer LR, Harrell PT, Meade CD, Craig BM, Lee JH, Brandon TH. A randomized clinical trial of self-help intervention for smoking cessation: Research design, interventions, and baseline data. Contemporary Clinical Trials. 2014 July; 38(2), 284-290. PMID: 24865525. PMCID: PMC4104245. 6. Craig BM, Reeve BB, Cella D, Hays RD, Pickard AS, Revicki DA. Demographic Differences in Health Preferences in the United States. Med Care. 2014 Apr; PMID: 24374420. PMCID: PMC4031273. 7. Craig BM, Hays RD, Pickard AS, Cella D, Revicki DA, Reeve BB. Comparison of US Panel Vendors for Online Surveys. J Med Internet Res. 2013 Nov 29;15(11):e260. PMID: 2429215. PMCID: PMC3869804. 8. Craig BM, Donovan KA, Fraenkel L, Watson V, Hawley S, Quinn GP. A generation of childless women: lessons from the United States. Women’s Health Issues. 2014 Jan-Feb;24(1):e21-7. PMID: 24439943. 9. Craig BM, Pickard AS, Lubetkin EI. Health problems are more common, but less severe when measured using newer EQ-5D versions. J Clin Epidemiol. 2014 Jan;67(1):93-9. PMID: 24075597. PMCID: PMC4091801. 10. Kessler LM, Craig BM, Reed DR, Quinn GP, Plosker S. Infertility Evaluation and Treatment among Women in the United States. Fertil Steril. 2013 Oct;100(4):1025-32. PMID: 23849845. PMCID: PMC3814221. 11. Craig BM, Pickard AS, Stolk E, Brazier JE. US Valuation of the SF-6D. Med Decis Making. 2013 Aug;33(6):793-803. PMID: 23629865. PMCID: PMC3740344. 12. Craig BM, Han G, Munkin MK, Fenstermacher D. Simulating the contribution of a biospecimen and clinical data repository in a phase II clinical trial: a value of information analysis. Stat Methods Med Res. 2013 Mar 15. [Epub ahead of print]. PMID: 23503303. PMCID: PMC3752320. 13. Kessler LM, Craig BM, Saigal C, Quinn GP. Starting a Family: Characteristics Associated With Men's Reproductive Preferences. Am J Mens Health. 2013 May;7(3):198-205. Epub 2012 Oct 29. PMID: 23112251. PMCID: PMC3708672. 14. Tarn DM, Young HN, Craig BM. Development of the patient approach and views toward healthcare communication (PAV-COM) measure among older adults. BMC Health Serv Res. 2012 Aug 30; 12:289. PMID: 22931537. PMCID: PMC3496598. 15. Pidala J, Craig BM, Lee S, Majhail N, Quinn GP, Anasetti C. Practice variation in physician referral for allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2013 Jan;48(1):63-7. PMID: 227905801. PMCID: PMC3549547. 16. Craig BM, Rollison DE, List AF, Cogle CR. Underreporting of myeloid malignancies by United States cancer registries. Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):474-81. PMID: 22237987. PMCID: PMC3662977. 17. Craig BM, Rollison DE, List AF, Cogle CR. Diagnostic Testing, Treatment, Cost of Care, and Survival among Registered and Non-registered Patients with Myelodysplastic Syndromes. Leuk Res. 2011 Nov; 35(11):1453-6. PMID: 21851978. PMCID: PMC3191243. Page 13 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 18. Adams R, Craig BM, Veale D, Bresnihan B, Walsh C, FitzGerald O, Barry M. The Impact of a Revised EQ-5D Population Scoring on Preference-based Utility Scores in an Inflammatory Arthritis cohort. Value Health. 2011 Sep-Oct;14(6):921-7. PMID: 21914514. PMCID: PMC3811927. 19. Craig BM, Busschbach JJV. Revisiting United States Valuation of EQ-5D States. J Health Econ. 2011 Sep 30; (5):1057-63. PMID: 21835477. PMCID: PMC3188390. 20. Rowen D, Brazier J, Young T, Gaugris S, King MT, Craig, BM, Velikova G. Deriving a PreferenceBased Measure for Cancer using the EORTC QLQ-C30. Value Health. 2011 Jul-Aug;14(5):721-31. PMID: 21839411. PMCID: PMC3811066. 21. Craig BM, Busschbach JJV. Toward a more universal approach in health valuation. Health Econ. 2011 Jul; 20(7):864-75. PMID: 20677328. PMCID: PMC3819815. 22. Cogle CR, Craig BM, Rollison DE, List AF. Incidence of the Myelodysplastic Syndromes using a Novel Claims-Based Algorithm: High Number of Uncaptured Cases by Cancer Registries. Blood. 2011 Jun 30;117(26):7121-5. PMID: 21531980. PMCID: PMC3143554. 23. Craig BM, Bell BA, Quinn GP, Vadaparampil ST. Prevalence of Cancer Visits by Physician Specialty, 1997-2006. J Cancer Educ. 2010 Dec;25(4):548-55. PMID: 20336400. PMCID: PMC3811914. 24. Craig BM, Gilbert SM, Herndon JB, Vogel B, Quinn GP. Participation of older patients with prostate cancer in Medicare eligible trials. J Urol. 2010 Sep;184(3):901-6. PMID: 20643449. PMCID: PMC3811922. 25. Craig BM, Brisson M, Chesson H, Giuliano AR, Jit M. Proceedings of the Modeling Evidence in HPV Pre-Conference Workshop in Malmö, Sweden, May 9-10, 2009. Clin Ther. 2010 Aug;32(8):1546-64. PMID: 20728767. PMCID: 4095755. 26. Craig BM, Strassels S. Out-of-Pocket Prices of Opioid Analgesics in the United States, 1999-2004. Pain Med. 2010 Feb;11(2):240-7. PMID: 20002589. PMCID: PMC3811926. 27. Craig BM, Oppe M. From a different angle: a novel approach to health valuation. Soc Sci Med. 2010 Jan;70(2):169-74. PMID: 19880235. PMCID: PMC2808428. 28. Craig BM, Quinn G, Vadaparampil S. Sensitivity of self-report mammography use in older women. Am J Prev Med. 2009 Nov;37(5):441-4. PMID: 19840700. PMCID: PMC3864094. 29. Augustovski FA, Irazola VE, Velazquez AP, Gibbons L, Craig BM. Argentine Valuation of the EQ-5D Health States. Value Health. 2009 Jun;12(4):587-96. PMID: 19090257. PMCID: PMC3819816. 30. Rakel DP, Hoeft TJ, Barrett BP, Chewning BA, Craig BM, Niu M. Practitioner Empathy and the Duration of the Common Cold. Fam Med. 2009 Jul-Aug;41(7):494-501. PMID: 19582635. PMCID: PMC2720820. 31. Craig BM, Adams AK. Accuracy of Body Mass Index Categories Based on Self-reported Height and Weight among Women in the United States. Matern Child Health J. 2009 Jul;13(4):489-96. PMID: 18607705. PMCID: PMC2731685. 32. Craig BM, Busschbach JJV, Salomon J. Modeling Ranking, Time Trade-Off and Visual Analogue Scale Values for EQ-5D Health States: A Review and Comparison of Methods. Med Care. 2009 Jun;47(6):63441. PMID: 19433996. PMCID: PMC2730922. 33. Craig BM, Busschbach JJV, Salomon J. Keep It Simple: Ranking Health States Yields Values Similar to Cardinal Measurement Approaches. J Clin Epidemiol. 2009 Mar;62(3):296-305. PMID: 18945585. PMCID: PMC2766172. 34. Craig BM. The duration effect: a link between TTO and VAS values. Health Econ. 2009 Feb;18(2):21725. PMID: 18351621. PMCID: PMC2760230. 35. Craig BM, Busschbach JJV. The Episodic Random Utility Model Unifies Worse Than Death and Better Than Death TTO Responses in Health State Valuation. Popul Health Metr. 2009 Jan 13;7:3. PMID: 19144115. PMCID: PMC2667164. Page 14 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 36. Craig BM, Kraus C, Davis J, Chewning B. Quality of care for older adults with chronic obstructive pulmonary disease and asthma based on comparisons to practice guidelines and smoking status. BMC Health Serv Res. 2008 Jul 8;8:144. PMID: 18611245. PMCID: PMC2500012. 37. Lundy JJ, Craig BM. The use of disease-modifying agents among multiple sclerosis patients enrolled in medicare from 1995 to 2002 and the impact of medicare part D: analysis of claims data from the medicare current beneficiary survey. Clin Ther. 2006 Jan;28(1):140-5. PMID: 16490588. 38. Craig BM, Ramachandran S. Relative Risk of a Shuffled Deck: A Generalizable Logical Consistency Criterion for Sample Selection in Health State Valuation Studies. Health Econ. 2006 Aug;15(8):835-48. PMID: 16532509. 39. Herman P, Craig BM, Caspi O. Is Complementary and Alternative Medicine (CAM) Cost-Effective? A Systematic Review. BMC Complement Altern Med. 2005 Jun 2;5:11. PMID: 15932647. PMCID: PMC1182346. 40. Fryback D, Craig BM. Measuring economic outcomes of cancer. J Natl Cancer Inst Monogr. 2004;(33):134-41. PMID: 15504924. 41. Craig BM, Kreling DH, Mott DA. Do Seniors Get The Medicines Prescribed For Them? Evidence From the 1996-1999 Medicare Current Beneficiary Survey. Health Aff (Millwood). 2003 May-Jun;22(3):17582. PMID: 12757282. 42. Craig BM, Tseng DS. Cost-effectiveness of Gastric Bypass for Severe Obesity. Am J Med. 2002 Oct 15;113(6):491-8. PMID: 12427499. 43. Craig BM, Koc C. Vice-President Al Gore’s Health Care Agenda and the Utilization of Medical Services: An Empirical Analysis. MedGenMed. 2000 Oct 27;2(4):E33. PMID: 11104479. Papers in Published Proceedings: 1. Craig BM, Ramos Goñi JM, Shaw JW, Flynn TN. Majority Rule: How to integrate TTO and DCE responses to increase construct validity and reduce parameter uncertainty. Proceedings of the 30th Scientific Plenary Meeting of the EuroQol Group, September 2013. 2. Craig BM, Brown DS, Cunningham C, Greiner W, Reeve BB. United States Valuation of Child Health Outcomes. Proceedings of the 30th Scientific Plenary Meeting of the EuroQol Group, September 2013. 3. Craig BM. From a different angle: a novel approach to health valuation. Proceedings of the 26th Scientific Plenary Meeting of the EuroQol Group, 121-135, September 2009. 4. Craig BM, Pickard S. Variability in QALY values for chronic conditions. Proceedings of the 26th Scientific Plenary Meeting of the EuroQol Group, 155-164, September 2009. 5. Augustovski FA, Irazola VE, Velazquez AP, Gibbons L, Craig BM. To develop a set of EQ-5D health state values for the Argentine general population. Proceedings of the 25th Scientific Plenary Meeting of the EuroQol Group, 133-148, September 2008. 6. Craig BM, Busschbach JJV. Replacing ad hoc adjustments for TTO values below death with a consistent theoretical model: increasing validity and power. Proceedings of the 25th Scientific Plenary Meeting of the EuroQol Group, 199-214, September 2008. 7. Gu NY, Craig BM, Doctor J. Diagnosing the EQ-5D items using the Rasch Models in a US Representative Sample. Proceedings of the 25th Scientific Plenary Meeting of the EuroQol Group, 309330, September 2008. 8. Craig BM, Busschbach JJV, Salomon J. International Valuation Set for EQ-5D Health States. Proceedings of the 24th Scientific Plenary Meeting of the EuroQol Group, 301-318, September 2007. 9. Craig BM, Busschbach JJV, Salomon J. Ordinal valuation of health states: a seven country study. Proceedings of the 23rd Scientific Plenary Meeting of the EuroQol Group, 415-435, August 2006. Page 15 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 Other Peer-Reviewed Papers: 1. Barham B, Coomes O, Craig BM. Uso de recursos por los ribereños en la Reserva Nacional PacayaSamiria: Datos de una encuesta reciente e implicaciones para el manejo del area protegida. Espacio y Desarrollo, 8: 5-32, 1996. Book Chapters 1. 2. 3. 4. Coons SJ, Craig BM. Assessing human and economic benefits of cancer prevention. In: Fundamentals of Cancer Prevention, third edition. DS Alberts & LM Hess (Eds). Springer-Verlag, 2014. Coons SJ, Craig BM. Assessing human and economic benefits of cancer prevention. In: Fundamentals of Cancer Prevention, second edition. DS Alberts & LM Hess (Eds). Springer-Verlag, pp13-30, 2008. Coons SJ, Craig BM. Assessing human and economic benefits of cancer prevention. In: Fundamentals of Cancer Prevention, first edition, DS Alberts & LM Hess (Eds.) Springer-Verlag, pp11-24, 2005. Gould, E, Craig BM, Nahl M, et al. Health Insurance, National Approaches. In: Encyclopedia of Aging, New York: Macmillan Reference. D. J. Ekerts (Eds.) pp593-600, 2002. Other Research and Creative Works 1. 2. 3. 4. 5. 6. 7. 8. 9. Craig BM, Mühlbacher AC. Patient’s Choices Define Value: Why we should listen to consumers and citizens. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Connections. Vol. 19(Compendium), 2013. González JM, Craig BM, Mühlbacher AC. Choice Defines Value: Using Discrete-Choice Experiments to Understand and Inform Health Care Decisions. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Connections. Vol. 19(2), 2013. Craig BM, Reeve BB. Patient-Reported Outcomes and Preference Research: Igniting the Candle at Both Ends and the Middle. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Connections. Vol. 18(5):24, 2012. Craig BM. Thoughts on the Validity of a New QALY Estimator [Response]. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Connections. Vol. 16(1):24, 2010. Craig BM. Authorship in Economic Evaluations. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Connections. Vol. 14(1): 23-24, 2008. Craig BM. Career Pathways in Pharmacoeconomics and Outcomes Research. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Connections. Vol. 13(5): 21, 2007. Craig BM, Benish K, Lipscomb J. PRODUCE Results Today! The Motivation behind the Next National Cancer Act. Working Paper, Moffitt Cancer Center, Tampa, Florida. pp. 1-34. December 17, 2007. Coomes OT, Barham BL, Craig BM. Resource extraction and the forest peasant household: Results of analyses of IIAP data from the Pacaya-Samiria National Reserve. Working Paper, the Nature Conservancy, Arlington, VA. pp. 1-38, 1996. Barham BL, Coomes OT, Craig BM, Tarasoff P. Wealth and the forest peasant household: Evidence from the Tahuayo and the Pacaya-Samiria National Reserve. Working Paper, the Nature Conservancy, Arlington, VA. pp. 1-26 1995. Scientific Abstracts/Podium Presentations/Poster Presentations 1. Craig BM, Brown DS, Reeve BB. The Value Adults Place on Child Health and Functional Status [poster], International Society for Pharmacoeconomics and Outcomes Research, 20th Annual Meeting, Philadelphia, Pennsylvania, USA, May 2015. 2. Craig BM, Greiner W, Brown DS, Reeve BB. Valuation of Child Health-related Quality of Life in the United States [poster], International Society for Pharmacoeconomics and Outcomes Research, 20th Annual Meeting, Philadelphia, Pennsylvania, USA, May 2015. Page 16 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 3. Craig BM, Mitchell SA. The Value Women Place on Menopausal Symptoms [poster], , International Society for Pharmacoeconomics and Outcomes Research, 20th Annual Meeting, Philadelphia, Pennsylvania, USA, May 2015. 4. Hartman J, Craig BM, Brown DS. Prevalence and Losses in Quality-Adjusted Life Years of Child Health Conditions: a Burden of Disease Analysis [poster], International Society for Pharmacoeconomics and Outcomes Research, 20th Annual Meeting, Philadelphia, Pennsylvania, USA, May 2015. 5. Runge SK, Craig BM, Reeve BB. Choosing between the PROMIS Global And EQ-5D for Comparative Effectiveness Research: Are They Really Different? [poster], International Society for Pharmacoeconomics and Outcomes Research, 20th Annual Meeting, Philadelphia, Pennsylvania, USA, May 2015. 6. Craig BM. Fifth Wheel: Evidence of Disagreements between Health Scales and Preferences in the EQ5D [poster], International Society for Quality of Life Research, 21st Annual Conference, Berlin, Germany. October 2014. 7. Craig BM. United States Valuation of the EQ-5D-3L, EQ-5D-Y, and EQ-5D-5L [poster], EuroQol Group. 31st Plenary Meeting. Stockholm, Sweden. September 2014. 8. Craig BM, Reeve BB, Brown PM, Cella D, Hays RD, Lipscomb J, Pickard AS, Revicki DA. Valuation of Health Outcomes Measured Using the PROMIS-29, Conjoint Analysis in Healthcare, Dana Point, California, USA. October 2013. 9. Craig BM, Reeve BB, Brown PM, Cella D, Hays RD, Lipscomb J, Pickard AS, Revicki DA. Valuation of Health Outcomes Measured Using the PROMIS-29, International Society for Quality of Life Research, 20th Annual Conference, Miami, Florida, USA. October 2013. 10. Craig BM, Brown DS, Greiner W, Reeve BB. United States Valuation of Child Health Outcomes [Poster], International Society for Quality of Life Research, 20th Annual Conference, Miami, Florida, USA. October 2013. 11. Craig BM, Brown DS, Cunningham C, Greiner W, Reeve BB. United States Valuation of Child Health Outcomes, EuroQol Group. 30th Plenary Meeting. Montreal, Canada. September 2013. 12. Craig BM, Ramos Goñi JM, Shaw JW, Flynn TN. Majority Rule: How to Integrate TTO and DCE Responses to Increase Construct Validity and Reduce Parameter Uncertainty, EuroQol Group. 30th Plenary Meeting. Montreal, Canada. September 2013. 13. Ratcliffe J, Chen G, Craig BM, Stevens K, Brazier J, Huynh E, Sawyer M, Roberts R, Flynn TN. Assessing the health related quality of life of Australian adolescents: findings from application of the EQ5D-Y in a community based on-line survey [poster], EuroQol Group. 30th Plenary Meeting. Montreal, Canada. September 2013. 14. Craig BM, Brown DS, Cunningham C, Greiner W, Reeve BB. United States Valuation of Child Health Outcomes [poster], International Society for Pharmacoeconomics and Outcomes Research, 15th Annual European Congress, Berlin, Germany, November 2012. 15. Craig BM, Watson V, Busschbach JJV. Choice-based valuation of the SF-12v1[poster], International Society for Pharmacoeconomics and Outcomes Research, 15th Annual European Congress, Berlin, Germany, November 2012. 16. Craig BM, Watson V. Choice-based Valuation of the SF-12. The 4th Conjoint Analysis in Health Conference. Orlando, Florida, USA. March 2012. 17. Lengacher CA, Jim H, Reich R, Pracht E, Craig BM, Ramesar R, Carranza I, Paterson C, Budhrani P, Millette L, Hogue DL, Wooten K, Mogos M, Johnson Mallard V, Santiago S, Miglore M, Dameron M, Kip KE. Improving Quality of Life in Breast Cancer Survivors: The Cost-Effectiveness of Mindfulness Based Stress Reduction [poster]. 9th Annual Conference of the American Psychosocial Oncology Society. Miami, Florida, USA. February 2012. 18. Craig BM. Arctangent Model for Conjoint Analysis. American Health Econometrics Working Group. Ann Arbor, Michigan. October 2010. 19. Gu NY, Bond TG, Craig BM. Evaluating the Measurement Properties of an Augmented EQ-5D Using the US National Representative Sample. International Conference on Outcomes Measurement. Bethesda, Maryland, USA. September 2010. Page 17 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 20. Oppe M, Craig BM. From a different angle: The use of directional statistics in ICER calculations. 8th European Conference on Health Economics. Helsinki, Finland. July 2010. 21. Adams R, Craig BM, Walsh C, Veale D, Bresnihan B, Barry M, FitzGerald O. A revised scoring system for the EQ-5D produces a change in preference-based utility score, which is closer to disease measures in inflammatory arthritis. 8th HTAi 2010 Conference. Dublin, Ireland. June 2010. 22. Craig BM, Brazier J. Unchained Melody: Revisiting the estimation of SF-6D values. American Society of Health Economists (ASHE), Health, Healthcare & Behavior. 3rd Biennial Conference. Ithaca, New York, USA. June 2010. 23. Craig BM, Busschbach JJV. Revisiting United States Valuation of EQ-5D States [poster]. American Society of Health Economists (ASHE), Health, Healthcare & Behavior. 3rd Biennial Conference. Ithaca, New York, USA. June 2010. 24. Gu NY, Bond TG, Craig BM. Evaluating the measurement properties of an augmented EQ-5D with the inclusion of two single quality-of-life (QOL) indicators using the Medical Expenditure Panel Survey (MEPS). International Society for Pharmacoeconomics and Outcomes Research (ISPOR). 15th Annual Conference. Atlanta, Georgia, USA. May 17, 2010. 25. Craig BM. From a different angle: a novel approach to health valuation. EuroQol Group. 26th Plenary Meeting. Paris, France. September 2009. 26. Craig BM, Pickard S. Variability in QALY values for chronic conditions. EuroQol Group. 26th Plenary Meeting. Paris, France. September 2009. 27. Gu NY, Bond TG, Bjork S, Craig BM. (EQ-5D + VAS) x RASCH = HRQoL measure [poster]. EuroQol Group. 26th Plenary Meeting. Paris, France. September 2009. 28. Craig BM, Salomon J, Busschbach JJV. Re-estimation of United States Values for EQ-5D Health States [poster]. EuroQol Group. 26th Plenary Meeting. Paris, France. September 2009. 29. Craig BM, Busschbach JJV. Towards a more universal approach in health valuation [poster]. EuroQol Group. 26th Plenary Meeting. Paris, France. September 2009. 30. Craig BM. Weber's QALYs: DCE and TTO estimates are nearly identical. Health Economics Study Group (HESG). Sheffield, England, UK. July 23, 2009. 31. Abimbola T, Craig BM, Rollison DE, Kumar A, Giuliano A. Evidence synthesis for modeling the natural history of anal penile and oropharyngeal cancers [poster]. International Society for Pharmacoeconomics and Outcomes Research (ISPOR). 16th Annual Conference. Orlando, Florida, USA. May 18, 2009. 32. Craig BM, Abimbola T, Rollison DE, Kumar A, Giuliano A. Modeling Anal/Penile Cancer in HVP Vaccination [poster]. International Papillomavirus Society (IPVS). 25th Annual Conference. Malmö, Sweden. May 12, 2009. 33. Craig BM, Busschbach JJV, Oppe M. Revisiting the estimation of QALYs [workshop]. International Society for Pharmacoeconomics and Outcomes Research (ISPOR). 14th Annual Conference. Orlando, Florida, USA. May 18, 2009. 34. Craig BM, Oppe M. From a different angle: A novel approach to health valuation. Second Conjoint Analysis in Health Conference. Delray Beach, Florida, USA. March 26, 2009. 35. Craig BM, Renewing the War on Cancer [Plenary]. Association of Cancer Executives. 15th Annual Meeting. Sarasota, Florida, USA. February 16, 2009. 36. Gu NY, Craig BM, Doctor J. Diagnosing the EQ-5D items using the Rasch Models in a US Representative Sample. EuroQol Group. 25th Plenary Meeting. Lake Maggiore, Italy. September 2008. 37. Augustovski FA, Irazola VE, Velazquez AP, Gibbons L, Craig BM. Argentine Valuation of the EQ-5D Health States. EuroQol Group. 25th Plenary Meeting. Lake Maggiore, Italy. September 2008. 38. Craig BM, Busschbach JJV. Sample Size and State Selection Considerations in EQ-5D Valuation Studies. EuroQol Group. 25th Plenary Meeting. Lake Maggiore, Italy. September 2008. 39. Craig BM, Busschbach JJV, Salomon J. International Valuation Set for EQ-5D Health States [poster]. American Society of Health Economists (ASHE), Equity and Efficiency in Health and Healthcare. 2nd Biennial Conference. Durham, North Carolina, USA. June 2008. Page 18 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 40. Craig BM, Busschbach JJV, Salomon J. International Valuation Set for EQ-5D Health States [poster]. International Society for Pharmacoeconomics and Outcomes Research (ISPOR). 13th Annual Conference. Toronto, Ontario, Canada, May 2008. 41. Craig BM, Busschbach JJV, Salomon J. International Valuation Set for EQ-5D Health States. EuroQol Group. 24th Plenary Meeting. Der Haag, the Netherlands. September 2007. 42. Craig BM, Busschbach JJV, Salomon J. Ordinal valuation of health states: an eight country study [poster]. International Health Economics Association. (iHEA) 6th World Congress. Copenhagen, Denmark. July 2007. 43. Craig BM, Strassels S. Out-Of-Pocket Prices of Opioid Analgesics in the United States [poster]. International Society of Pharmacoeconomics and Outcomes Research (ISPOR). 12thAnnual Conference. Washington, District of Columbia, USA. May 2007. 44. Craig BM, Busschbach JJV, Salomon J. Ordinal valuation of health states: a seven country study. EuroQol Group. 23rd Annual Conference. Barcelona, Spain. September 2006. 45. Craig BM, Deb P. A multimodal model of health care prices American Society of Health Economists (ASHE) Economics of Population Health. Inaugural Conference. Madison, Wisconsin, USA. June 2006. 46. Craig BM, Deb P. Out-of-pocket price of outpatient medications in the United States [poster]. International Society of Pharmacoeconomics and Outcomes Research (ISPOR). 11th Annual Conference. Philadelphia, Pennsylvania, USA. May 2006. 47. Ramachandran S, Craig BM, Coons SJ. Equivalence of paper and touch screen versions of the EQ-5D Visual Analog Scale (EQ-VAS) [poster]. International Society for Quality of Life Research. 12th Annual Conference. Washington, District of Columbia, USA. October 2005. 48. Salomon J, Craig BM. Estimating health state valuation functions based on ordinal ranking data: findings from a United States EQ-5D valuation study [poster]. International Health Economics Association (iHEA) 5th World Congress. Barcelona, Spain. July 2005. 49. Craig BM. Duration Dependence: a bridge between visual analog scale and time trade-off values [poster]. International Health Economics Association (iHEA) 5th World Congress. Barcelona, Spain. July 2005. 50. Chongpison Y, Craig BM, Coons SJ. Potential Impact of Health Status on Life Satisfaction and Quality of Life: A Pilot Study [poster]. International Society of Pharmacoeconomics and Outcomes Research (ISPOR.) 10th Annual Conference. Washington, District of Columbia, USA. May 2005. 51. Ramachandran S, Craig BM, Coons SJ. Equivalence of Paper and Touch Screen Versions of the EQ-5D Visual Analog Scale (EQ-VAS) [poster]. International Society of Pharmacoeconomics and Outcomes Research (ISPOR). 10th Annual Conference. Washington, District of Columbia, USA. May 2005. 52. Lundy JJ, Craig BM. The Impact of Medicare Part D on Economic Barriers to Prescription Medications among Beneficiaries with Multiple Sclerosis [poster]. International Society of Pharmacoeconomics and Outcomes Research (ISPOR). 10th Annual Conference. Washington, District of Columbia, USA. May 2005. 53. Mahmood MH, Craig BM, Ko Y, Armstrong E. Trends in the Prevalence of Inappropriate Prescribing among Elderly Medicare Beneficiaries, 1992-2001 [poster]. International Society of Pharmacoeconomics and Outcomes Research. (ISPOR). 10th Annual Conference. Washington, District of Columbia, USA. May 2005. 54. Craig BM, Ramachandran S, Coons SJ. Self-Assessed Health Status in the United States: EQ-5D Findings from the Medical Expenditure Panel Survey [poster]. International Society of Pharmacoeconomics and Outcomes Research (ISPOR). 10th Annual Conference. Washington, District of Columbia, USA. May 2005. 55. Herman P, Craig BM, Caspi O. Is Complementary and Alternative Medicine (CAM) Cost-Effective? A Systematic Review [poster]. Association for Women Faculty. Graduate Showcase of Women’s Research. Tucson, Arizona, USA. March 2005. 56. Chongpison Y, Craig BM, Coons SJ. Potential Impact of Health Status on Life Satisfaction and Quality of Life: A Pilot Study [poster]. First Western Pharmacoeconomics Conference. Salt Lake City, Utah, USA. March 2005. Page 19 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 57. Ramachandran S, Craig BM, Coons SJ. Equivalence of Paper and Touch Screen Versions of the EQ-5D Visual Analog Scale (EQ-VAS) [poster]. Benefits and Challenges with ePRO: Outcomes and Endpoints as We Emerge from the Long Age of Paper. Drug Information Association Workshop. Arlington, Virginia, USA. April 2005. 58. Craig BM. Out-of-pocket Price, Prescription Medications and Seniors [poster]. Academy Health. 2003 Annual Research Meeting. Nashville, Tennessee, USA. June 2003. 59. Craig BM. Drug Coverage and the Out-of-pocket Price for Prescription Medications Among Elderly Medicare Beneficiaries [poster]. International Health Economics Association (iHEA) 4th World Congress. San Francisco, California, USA, June 2003. 60. Corden TE, Skoumal KS, Hubbard JM, Sheppard MA, Craig BM. Helmet Legislation Effect On Pediatric Bicycle-Related Head Injury Hospital Admissions in Wisconsin and the United States [poster]. 1st San Diego Pediatric Trauma Conference. San Diego, California, USA. October 2002. 61. Craig BM, Koc C. The Moral Hazard Effect of Insurance across Health Cohorts [poster]. International Health Economics Association (iHEA) 3rd World Congress. York, England. July 2001. 62. Craig BM, Koc C. The Moral Hazard Effect of Insurance across Health Cohorts [poster]. Academy for Health Services Research and Health Policy. Annual Meeting. Atlanta, Georgia, USA. June 2001. 63. Craig BM, Kind P. Logical Consistency and the Valuation of Health: An Analysis of US Survey Data. International Society of Pharmacoeconomics and Outcomes Research (ISPOR). 6th Annual Meeting. Arlington, Virginia, USA. May 2001. 64. Craig BM, Tseng DS. Dollars per Pound: A Cost-effectiveness Analysis of Obesity Treatments. Society for Medical Decision Making. Annual Meeting. Cincinnati, Ohio, USA. October 2000. 65. Craig BM, Koc C. The Gore Plan and the Utilization of Medical Services [poster]. Association for Health Services Research. Annual Meeting. Los Angeles, California, USA. June 2000. 66. Craig BM, Koc C. Insurance Endogeneity, Moral Hazard and the Demand for Health Care [poster]. Association for Health Services Research. Annual Meeting. Los Angeles, California, USA. June 2000. 67. Craig BM, Koc C. The Intensity of Moral Hazard across Medical Services. 4th Texas Camp Econometrics. Lake Texacoma, Texas, USA. February 1999. Invited Podium Presentations International: 1. 2015 Academy Webinar, International Academy of Health Preference Research, Moffitt Cancer Center, Tampa, Florida, USA, February 2015. 2. Challenges in the Valuation of Health: Men, Women and Children, Centre for Health Economics, Monash University, Clayton, Victoria, Australia, November 2014. 3. Choice Defines Value: Interpretation of Criteria Weights in Multi-Criteria Decision Making, International Society for Pharmacoeconomics and Outcomes Research, 17th Annual European Congress, Amsterdam RAI, Amsterdam, The Netherlands, November 2014. 4. Benefit Assessment and Patient Preferences, Bundesverband Managed Care e.V., Berlin, Germany, October, 2014. 5. Choice Defines Value: Turning preferences of multiple stakeholders into evidence for health care decision making, International Society for Pharmacoeconomics and Outcomes Research, 21st Annual Meeting, Palais des Congrès de Montréal, Montreal, Quebec, Canada, June 2014 (workshop). 6. Choice Defines Value: New Approaches to evaluating multiple treatment attributes and health outcomes, International Society for Pharmacoeconomics and Outcomes Research, 20th Annual Meeting, New Orleans, Louisiana, USA, May 2013 (workshop). 7. Discrete Choice and Health Valuation, Bundesverband Managed Care e.V., Berlin, Germany, November 2012. Page 20 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 8. Choice Defines Value: New Approaches to estimating QALYs, HYEs, and efficiency frontiers, International Society for Pharmacoeconomics and Outcomes Research, 15th Annual European Congress, Berlin, Germany, November 6, 2012 (workshop). 9. US valuation of child health outcomes, Youth Taskforce, EuroQol Group, Amsterdam, the Netherlands, May 2012. 10. How to translate PROs into Irish QALYs using the internet, Irish National Centre for Pharmacoeconomics, Trinity College Dublin, Dublin, Ireland. July 2011. 11. Incorporating Patient Reported Outcome Measures into US Comparative Effectiveness Research, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, UK, June 2011 12. How to translate PRO into QALYs using the internet, Centre for Health Economics, University of York, York, England, UK. June 2009. 13. Online Technological Constraints in Experimental Health Economics, Health Economics Research Unit, University of Aberdeen, Aberdeen, Scotland, UK, June 2011. 14. The Emperor's New Clothes: revisiting QALY estimation, Health Economics Research Centre, Department of Public Health, University of Oxford, Oxford, England, UK. July 2009. 15. Towards a more universal approach in health valuation, Centre for Health Economics, University of York, York, England, UK. July 2009. 16. The Emperor is Naked: Revisiting Quality-adjusted Life Year (QALY) Estimation, Irish National Centre for Pharmacoeconomics, Trinity College Dublin, Dublin, Ireland. July 2009. 17. All models are wrong, but some are useful: the case of quality-adjusted life years (QALYs), Health Economics, School of Health and Population Sciences, University of Birmingham, Birmingham, England, UK. July 2009. 18. Revisiting UK QALY Estimates, Institute of Health and Society, Newcastle University, Newcastle, England, UK. July 2009. 19. Revisiting the UK EQ-5D and SF-6D QALY Estimates, Institute of Health Sciences, University of Leeds, Leeds, England, UK. July 2009. 20. Revisiting QALY Estimation, Health Economics and Decision Science (HEDS), University of Sheffield, Sheffield, England, UK. June 2009. 21. The Influence of Benjamin Franklin's Prudential Algebra on Public Health Policy, Health Economics and Decision Science (HEDS), University of Sheffield, Sheffield, England, UK. June 2009. 22. Episodic Random Utility Model for QALY Estimation. Health Economics and Decision Science (HEDS), University of Sheffield, Sheffield, England, UK. October 2008. 23. Valuing EQ- 5D with Time Trade-off for the Polish Population. 25th Plenary Meeting of the EuroQol Group, Lake Maggiore, Italy. September 2008. 24. Valuing Health: An Eight Country Study. Department of Community Health and Epidemiology Seminar, Dalhousie University, Halifax, Nova Scotia, Canada. October 2007. National: 1. Challenges in Health Preference Research: Men, Women, and Children, School of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA. March 2015 2. Challenges in Health Preference Research: Men, Women, and Children, Washington University in St. Louis, St. Louis, Missouri, USA. March 2015 3. Preference-based measurement strategies for PROMIS, 5th Psychometric Summit, Crystal City Marriott, Arlington, Virginia, USA. June 2014. 4. Health Valuation for Comparative Effectiveness Research. Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, California, USA. October 2013. 5. Cost-effectiveness of a Mindfulness Based Stress Reduction Program for Improving Quality of Life in Breast Cancer Survivors: Results from a Randomized Control Trial. Economic Supplement Meeting, Survivorship Office, National Cancer Institute. Bethesda, Maryland, USA. September 2013 Page 21 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 6. Between Chocolates and Cars: a re-interpretation of conventional choice models. Brown Bag Lunch Series, Health Preference Assessment, RTI Health Solutions, RTI International, Research Triangle Park, North Carolina, USA. May 2013. 7. Health Valuation for Comparative Effectiveness Research. School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA. April 2013. 8. Expressing the value of improved health-related quality of life (HRQOL) in terms of survival. Health Economics Statistics, Merck & Co. Inc., North Wales, Pennsylvania, USA. January 2013. 9. Enhancing Patient-Reported Outcomes for Comparative Effectiveness Research. Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. February 2012. 10. Translating cancer outcomes into QALYs using experimental economics. Cancer Outcomes/ICISS Seminar, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill. Chapel Hill, North Carolina, USA. October 2011. 11. The Next Generation of Quality-Adjusted Life Years for CER. Comparative Effectiveness Research Seminar, Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA. October 2011. 12. Methods in Online Discrete Choice Experiments. Brown Bag Lunch Series, Health Preference Assessment, RTI Health Solutions, RTI International, Research Triangle Park, North Carolina, USA. October 2011. 13. Enhancing Patient-Reported Outcomes for Comparative Effectiveness Research. Yale University, New Haven, Connecticut, USA. May 2011. 14. Enhancing Patient-Reported Outcomes for Comparative Effectiveness Research. University of Michigan, New Haven, Connecticut, USA. May 2011. 15. Understanding how choices reveal the value of health. Colorado School of Public Health, Denver, Colorado, USA. January 5, 2011. 16. Cumulating Health Outcomes in Comparative Effectiveness (CHOICE) Research. Virginia Commonwealth University, Richmond, Virginia, USA. October 14, 2010. 17. Comparing Health Outcomes in Comparative Effectiveness (CHOICE) Research: Do preferences matter? University of California, Los Angeles, Los Angeles, California, USA. July 13, 2010. 18. Valuing Health and Longevity for Public Policy. Institute for Child Health Policy. University of Florida. Gainesville, Florida, USA. January 14, 2009. 19. Oncopolitics and Policy. Researchers in Cancer Economics (RICE) Working Group Meeting. Principles and Practice of Cancer Prevention and Control Course. National Cancer Institute. Bethesda, Maryland, USA. July 21, 2008. 20. Health Technology Assessment in Cancer. Researchers in Cancer Economics (RICE) Working Group Meeting. Principles and Practice of Cancer Prevention and Control Course. National Cancer Institute. Bethesda, Maryland, USA. July 17, 2008. 21. Overview of Cancer Economics. Researchers in Cancer Economics (RICE) Working Group Meeting. Principles and Practice of Cancer Prevention and Control Course. National Cancer Institute. Bethesda, Maryland, USA. July 14, 2008. 22. Average versus Quantile Treatment Effects: Estimating Differential Outcomes between Alternative Treatment Therapies by Bijan J. Borah. American Society of Health Economists, Equity and Efficiency in Health and Healthcare. 2nd Biennial Conference. Durham, North Carolina, USA. June 23, 2008. [Invited discussant]. 23. Does the Promotion of Community-Level Social Capital Reduce Obesity Risk? by Jangho Yoon, University of California at Berkeley. American Society of Health Economists, Equity and Efficiency in Health and Healthcare. 2nd Biennial Conference. Durham, North Carolina, USA. June 24, 2008. [Invited discussant]. 24. Does Mothers’ Willingness To Pay for Children's Health Differ from Fathers? by Soyeon Guh, University of North Carolina at Chapel Hill. American Society of Health Economists, Equity and Efficiency in Page 22 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. Health and Healthcare. 2nd Biennial Conference. Durham, North Carolina, USA. June 23, 2008. [Invited discussant]. Research on Medicare Part D and Reimbursement Policies II. International Society for Pharmacoeconomics and Outcomes Research. 15th Annual Conference. Toronto, Ontario, Canada. May 5, 2008. [Session moderator]. Estimating the Welfare Effects of Alternative Liability Regimes by Eric Sun and Tomas Philipson. Annual Health Economics Conference. Phoenix, Arizona, USA. March 2007. [Invited discussant]. Gamma Mixture Models and Their Use in Price and Expenditure Estimations. University of Southern California School of Pharmacy. Los Angeles, California, USA. September 2006. Price Shock: a common side effect of appropriate care. Mayo Clinic. Rochester, Minnesota, USA. July 2006. What do we pay for appropriate care? Division of Social and Administrative Sciences, School of Pharmacy, University of Wisconsin-Madison. Madison, Wisconsin, USA. June 2006. Instrumental Variables in Addressing Selection Bias in Observational Studies. University of Arkansas, College of Pharmacy. Little Rock, Arkansas, USA. April 2006. A model of health care prices. Pharmaceutical Economics Group, School of Pharmacy, University of Iowa. Iowa City, Iowa, USA. April 2006. A model of health care prices. Department of Pharmacy Administration, College of Pharmacy, University of Illinois at Chicago. Chicago, Illinois, USA. March 2006. A model of health care prices. Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland. Baltimore, Maryland, USA. November 2005. A model of health care prices. Merck & Co., Inc. Blue Bell, Pennsylvania, USA. November 2005. A model of health care prices. Division of General Internal Medicine, School of Medicine, University of Pennsylvania. Philadelphia, Pennsylvania, USA. November 2005. A model of health care prices. Department of Health Policy and Administration, School of Public Health, University of North Carolina at Chapel Hill. Chapel Hill, North Carolina, USA. November 2005. Econometric Models of Expenditure. International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Webcast. USA. October 2005. Research Using the Medicare Current Beneficiary Survey. Sonderegger Research Center, School of Pharmacy, University of Wisconsin – Madison. Madison, Wisconsin, USA. June 2005. Regional: 1. Genitourinary Cancer Outcomes Research (GCOR) and Valuation Studies, the Movember Foundation, Moffitt Cancer Center, Tampa, Florida, USA, March 2, 2015 2. Health Preferences of Puerto Rico. U54 Ponce School of Medicine-Moffitt Cancer Center Partnership, Moffitt Cancer Center, Tampa, Florida, USA, August 27, 2014 3. Health Preference Research: an Introduction to Craig Lab, Moffitt Business Center, Moffitt Cancer Center, Tampa, Florida, June 26, 2014 4. Health Preference Research: an Introduction to Craig Lab, Moffitt Foundation, Moffitt Cancer Center, Tampa, Florida, February 14, 2014 5. Difficult Decisions in Health Care: Genetic Counseling and Women’s Health Preferences. Health Occupations Student Association, University of South Florida, Tampa, Florida, USA, March 21, 2013. 6. Enhancing Health Outcomes Measures for Comparative Effectiveness Research. 2012 Moffitt Scientific Symposium, Moffitt Cancer Center, Tampa, Florida, USA, May 10, 2012. 7. Innovation Section Workshop with Vani Nath Simmons. Health Outcomes and Behavior, Moffitt Cancer Center. Tampa, Florida, USA. Nov 4, 2011. 8. Smoking Research Collaborations in Pragmatic Online Experiments, Tobacco Research and Intervention Program, Moffitt Cancer Center. Tampa, Florida, USA. Sept 9, 2011. 9. Online Experimental Techniques for Social Science Research Workshop. Moffitt Cancer Center. Tampa, Florida, USA. May 5, 2011. Page 23 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 10. Economics Research at Moffitt Cancer Center. Clinical Fellows. Moffitt Cancer Center. Tampa, Florida, USA. September 13, 2010. 11. Simulating the contributions of a biorepository in a phase-2 clinical trial: a value of information analysis. Biostatistics Core. Moffitt Cancer Center. Tampa, Florida, USA. July 27, 2010. 12. Comparing Health Outcomes in Comparative Effectiveness Research: Do preferences matter? Grand Rounds. Moffitt Cancer Center. Tampa, Florida, USA. June 4, 2010. 13. The Arctangent Model in Conjoint Analysis. Biostatistics Core. Moffitt Cancer Center. Tampa, Florida, USA. May 10, 2010. 14. Participation of Cancer Patients in Clinical Trials. Moffitt Scientific Retreat. Moffitt Cancer Center. Tampa, Florida, USA. March 6, 2009. 15. Renewing the War on Cancer, Hematology-Oncology Fellows Seminar. Moffitt Cancer Center. Tampa, Florida, USA. February 11, 2009. 16. Directional Statistics in Health Econometrics. Health Economics Seminar. University of South Florida. Tampa, Florida, USA. November 21, 2008. 17. Renewing the War on Cancer. Pinellas Professional Partners. Moffitt Foundation. Tampa, Florida, USA. October 2, 2008. 18. The Estimation of Health Preferences. Biostatistics Core. Moffitt Cancer Center. Tampa, Florida, USA. September 26, 2008. 19. Cancer Economics Database (CED). Moffitt Cancer Center. Tampa, Florida, USA. May 22, 2008. 20. Valuing Health. Evidence-based Medicine and Decision Sciences Section. Moffitt Cancer Center. Tampa, FL. May 2008. 21. Valuing Health. Health Economics Seminar. University of South Florida. Tampa, Florida, USA. April 2008. 22. Assessment of Evaluative Technologies. Evidence-based Medicine and Decision Sciences Section. Moffitt Cancer Center. Tampa, Florida, USA. March 2008. 23. Assessment of Evaluative Technologies. Xcenda. Palm Harbor, Florida, USA. March 2008. 24. Introduction to Cancer Economic Evaluations. Health Outcomes & Behavior Meeting. Moffitt Cancer Center. Tampa, Florida, USA. February 2008. 25. Out-of-pocket prices for prescription medications: an application of mixture models. Health Economics Seminar. University of South Florida. Tampa, Florida, USA. February 2008. 26. Economics Research at Moffitt Cancer Center. Senior Adult Oncology Research Meeting. Moffitt Cancer Center. Tampa, Florida, USA. January 2008. 27. How it Might Reshape Oncology. Paul P. Carbone Comprehensive Cancer Center Grand Rounds. University of Wisconsin. Madison, Wisconsin, USA. October 2007. The National Cancer Act of 2007. 28. Do seniors get the medications prescribed for them and what do they pay? January Conference. The Center for Health Outcomes and PharmacoEconomic Research. Tucson, Arizona, USA. January 2006. 29. Overview of Cancer Economics. January Conference. The Center for Health Outcomes and PharmacoEconomic Research. Tucson, Arizona, USA. January 2005. 30. Measuring Economic Outcomes of Cancer. Cancer Prevention and Control Program Grand Rounds, Arizona Cancer Center. Tucson, Arizona, USA. November 2003. Other Education June 2012 October 2010 October 2010 Content Validity of PRO, ClinRO and ObsRO Assessments, Donald L. Patrick, Mona L. Martin, Chad Gwaltney, Nancy Kline Leidy, Pre-Conference Workshop, The International Society for Pharmacoeconomics and Outcomes Research, 17th Annual Conference, Washington, District of Columbia, USA. Choice-based Conjoint, Aaron Hill and Brian McEwan, Sawtooth Software PreConference Workshop, Newport Beach, California, USA. Applying Best-Worst Scaling in Health Care, Terry Flynn and Jordan Louviere, Sawtooth Software Pre-Conference Workshop, Newport Beach, California, USA. Page 24 of 25 Benjamin M. Craig, Ph.D. March 18, 2015 May 2010 Summer 2008 Summer 2008 May 2008 Spring 2008 Fall 2007 Spring 2007 Spring 2007 Fall 2006 Spring 2006 Spring 2006 July 2005 July 2005 July 2005 May 2005 Spring 2005 Spring 2005 Spring 2004 July 2002 July 2001 September 2000 Patient-Reported Outcomes – Item Response Theory, Bryce Reeve, Pre-Conference Workshop, The International Society for Pharmacoeconomics and Outcomes Research, 15th Annual Conference, Atlanta, Georgia, USA. Molecular Prevention Course, National Cancer Institute, Bethesda, Maryland, USA. The Principles and Practice of Cancer Prevention and Control Course, National Cancer Institute, Bethesda, Maryland, USA. Patient-Reported Outcomes - Item Response Theory, Lori McLeod, Cheryl Hill, Pre-Conference Workshop, The International Society for Pharmacoeconomics and Outcomes Research, 13th Annual Conference, Toronto, Ontario, Canada. Hematology-Oncology Fellowship Seminars and Journal Club, Kenneth Zuckerman, Moffitt Cancer Center, Tampa, Florida, USA. Medical Oncology Fellowship Seminars and Journal Club, James Stewart, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Clinical Nutrition, Gail Underbakke, Patrick McBride, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Principles of Human Physiology, Richard Moss, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Integrated Medical Anatomy, Karen Krabbenhoft, Edward Schultz, Gary Lyons, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Patient Registries: Overview and Application, Jeff Trotter, ISPOR Workshop, Philadelphia, Pennsylvania, USA. Cost-effectiveness Analysis Alongside Clinical Trials, Scott Ramsey, Richard Willke, ISPOR Workshop, Philadelphia, Pennsylvania, USA. Health Econometrics of Health Cost, Expenditure and Utilization Data, Partha Deb, Willard Manning, Edward Norton, iHEA World Congress, Barcelona, Spain. Risk Adjustment and Predictive Modeling, Randel Ellis, iHEA World Congress, Barcelona, Spain. Econometric Methods for Health Policy Analysis Using Non-Experimental Data, Joseph Terza, iHEA World Congress, Barcelona, Spain. CMS 301: Using SEER/Medicare Data for Research, ResDAC, Minneapolis, Minnesota, USA. Topics in Econometrics (ECON 696E), Keisuke Hirano, Department of Economics, Eller College of Management, The University of Arizona, Tucson, Arizona, USA. Causal Inference and Program Evaluation (ECON 696F), Keisuke Hirano, Department of Economics, Eller College of Management, University of Arizona, Tucson, Arizona, USA. Experimental Economics II (ECON 696B), Martin Duwenberg, Department of Economics, Eller College of Management, University of Arizona, Tucson, Arizona, USA. MiniMedical School for Social Scientists and Demography, Economics, and Epidemiology of Aging Conference, RAND Summer Institute, Santa Monica, California, USA. Medicare Current Beneficiary Survey Workshop, ResDAC, Minneapolis, Minnesota, USA. CMS 101: Introduction to the use of Medicare claims data for research, ResDAC, Minneapolis, Minnesota, USA. Page 25 of 25
© Copyright 2024